Skip to main content

Table 3 Adverse events for all patients in included RCTs

From: Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials

Author/reference

Facial asymmetry

Edema/hematoma at injection area

Exposed

Control

Disappearance

Exposed

Control

Disappearance

Zhang et al. [24]

3

0

6 weeks

2

0

5 days

Shehata et al. [26]

4

0

not reported

1

2

not reported

Wu et al [23]

5

0

7 weeks

2

1

7 days

Zúñiga et al [25]

2

0

not reported

2

0

not reported